Ledger.Open graph →

SEC Form D · filed March 10, 2021

eGenesis, Inc

Offering

$125.0M

Sold

$125.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Lucio L. Iannone · CAMBRIDGE, MADirector Julie Sunderland · CAMBRIDGE, MADirector Paul Sekhri · CAMBRIDGE, MAExec · Director Albert L. Wiegman · CAMBRIDGE, MADirector Steven Gillis · CAMBRIDGE, MADirector Sapna Srivastava · CAMBRIDGE, MAExec Isaac Ciechanover · Wellesley, MADirector Burke N. Brown · New York, NYDirector Matt Auriemma · Grand Cayman, Cayman IslandsDirector Joseph N. Hasselman · New York, NYDirector Patrick R. Leardo · Atlanta, GAExec · Director Andy R. Lary · Atlanta, GADirector Kathleen Fanning · Seattle, WADirector Peter Hanson · CAMBRIDGE, MAExec Michael Curtis · New York, NYExec Mark Pruzanski · CAMBRIDGE, MADirector Sarah Schlesinger · CAMBRIDGE, MADirector Peter Hughes · Newtown Square, PAExec · Director Meena Sankaran · Milpitas, CADirector Heidi Patel · Milpitas, CADirector Ollen Douglass · Milpitas, CADirector Levi C. Bernabe · VANCOUVER, British Columbia, CanadaDirector Kathleen Fanning · Seattle, WADirector Peter Hanson · CAMBRIDGE, MAExec Michael Curtis · Saint-Eustache, Quebec, CanadaExec Sapna Srivastava · CAMBRIDGE, MAExec Isaac Ciechanover · Wellesley, MADirector Mark Pruzanski · CAMBRIDGE, MADirector Sarah Schlesinger · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗